Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Title
Intervention Indication Therapeutic Area Year Actions
Belinostat (Beleodaq) with CHOP for treatment of patients with peripheral T‐cell lymphoma, 1st line Belinostat (Beleodaq; PXD101) , CHOP Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2017 View  |  Download
Benralizumab for Chronic Obstructive Pulmonary Disease (COPD) Benralizumab (Fasenra; MEDI563) Chronic obstructive pulmonary disease (COPD) Respiratory System 2017 View  |  Download
Biotin for Adrenomyeloneuropathy without cerebral involvement Biotin (MD1003; Qizenday; Vitamin B7) Adrenomyeloneuropathy (AMN) Genetic Disorders , Neurology 2017 View  |  Download
Blinatumomab (Blincyto) for First Relapsed/Refractory, B-precursor, Acute Lymphoblastic Leukaemia, in Children and Adolescents Blinatumomab (Blincyto) Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2017 View  |  Download
Bosutinib (Bosulif) for Philadelphia positive chronic myeloid leukaemia – first line Bosutinib (Bosulif; PF-05208763; bosutinib monohydrate) Chronic myeloid leukaemia (CML) Haematological Cancer and Lymphomas 2017 View  |  Download
Brentuximab vedotin (Adcetris) for treatment naive Hodgkin’s Lymphoma Adriamycin , Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2017 View  |  Download
Brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer Brigatinib (Alunbrig; AP26113) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Brolucizumab (ESBA1008; RTH258) for neovascular age-related macular degeneration (nAMD) Brolucizumab (RTH258; ESBA1008; Beovu) Age-related macular degeneration (AMD) Ophthalmology 2017 View  |  Download
BV-NSCLC- 002 (Cimavax) for non-small-cell lung cancer wild type EGF receptor positive patients EGF-PTI (CimaVax) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Cabozantinib for Hepatocellular Carcinoma Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications